Source: European Journal of Haematology. Unidade: FCF
Subjects: HEMOCROMATOSE, FERRO
ABNT
CANÇADO, Rodolfo et al. Deferasirox in patients with iron overload secon dary tohereditary hemochromatosis: results of a 1-yr Phase 2 study. European Journal of Haematology, 2015Tradução . . Disponível em: https://doi.org/10.1111/ejh.12530. Acesso em: 08 nov. 2024.APA
Cançado, R., Melo, M. R., Bastos, R. de M., Santos, P. C. J. L., Guerra-Shinohara, E. M., Chiattone, C., & Ballas, S. K. (2015). Deferasirox in patients with iron overload secon dary tohereditary hemochromatosis: results of a 1-yr Phase 2 study. European Journal of Haematology. doi:10.1111/ejh.12530NLM
Cançado R, Melo MR, Bastos R de M, Santos PCJL, Guerra-Shinohara EM, Chiattone C, Ballas SK. Deferasirox in patients with iron overload secon dary tohereditary hemochromatosis: results of a 1-yr Phase 2 study [Internet]. European Journal of Haematology. 2015 ;[citado 2024 nov. 08 ] Available from: https://doi.org/10.1111/ejh.12530Vancouver
Cançado R, Melo MR, Bastos R de M, Santos PCJL, Guerra-Shinohara EM, Chiattone C, Ballas SK. Deferasirox in patients with iron overload secon dary tohereditary hemochromatosis: results of a 1-yr Phase 2 study [Internet]. European Journal of Haematology. 2015 ;[citado 2024 nov. 08 ] Available from: https://doi.org/10.1111/ejh.12530